Highly dynamic changes of regional HBV epidemiology over two decades.

[1]  F. Morisco,et al.  Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country , 2022, Viruses.

[2]  T. Asselah,et al.  Endpoints and New Options for Treatment of Chronic Hepatitis D , 2021, Hepatology.

[3]  E. Sagnelli,et al.  Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  E. Sagnelli,et al.  Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study. , 2020, Travel medicine and infectious disease.

[5]  M. Massari,et al.  The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[7]  R. Granese,et al.  Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[8]  A. Andriulli,et al.  Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross‐sectional multicenter study , 2017, Journal of medical virology.

[9]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[10]  E. Sagnelli,et al.  Chronic HBV infection in pregnant immigrants: a multicenter study of the Italian Society of Infectious and Tropical Diseases. , 2016, The new microbiologica.

[11]  E. Sagnelli,et al.  Hepatitis B virus burden in developing countries. , 2015, World journal of gastroenterology.

[12]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[13]  M. Ciccozzi,et al.  Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. , 2015, Journal of travel medicine.

[14]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[15]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[16]  T. Stroffolini.  The changing pattern of hepatitis B virus infection over the past three decades in Italy. , 2005, Digestive and Liver Disease.

[17]  F. Mannelli,et al.  Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. , 2003, Vaccine.